Voyageur Pharmaceuticals Ltd.’s Post

Voyageur Pharmaceuticals Ltd. reposted this

Voyageur Pharmaceuticals Ltd. CEO Brent Willis joined Steve Darling from Proactive to announce the successful completion of formulation work for the company’s latest product line, which includes five Health Canada-licensed products. These advanced formulations are set to raise industry standards, offering enhanced value to healthcare providers and stakeholders. Willis also revealed the launch of two new product brands, Vision and Smooth barium contrast agents, aimed at improving versatility and performance in medical diagnostics. Watch at #Proactive #ProactiveInvestors http://ow.ly/F0rY105J5sj

Voyageur Pharmaceuticals announces new line of Barium Contrast Formulations setting new standard

Voyageur Pharmaceuticals announces new line of Barium Contrast Formulations setting new standard

proactiveinvestors.com

To view or add a comment, sign in

Explore topics